|
| 37514116 | mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines. | | 2023 |
| 37726776 | Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer. | | 2023 |
| 37206278 | Erythroleukemia: Classification. | | 2023 |
| 37007122 | -methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. | | 2023 |
| 36672396 | PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. | | 2023 |
| 36986799 | Prognostic and Predictive Value of Expression in Early Breast Cancer and by Molecular Subtype. | | 2023 |
| 35110528 | BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells. | Cell Death and Disease | 2022 |
| 35771388 | Low cholesterol biosynthesis favors epithelial-to-mesenchymal transition maintenance and influences tumor molecular subtyping and disease-free survival in colon cancer patients. | Cancer Communications | 2022 |
| 35771388 | Low cholesterol biosynthesis favors epithelial-to-mesenchymal transition maintenance and influences tumor molecular subtyping and disease-free survival in colon cancer patients. | Cancer Communications | 2022 |
| 35965534 | Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial. | Frontiers in Oncology | 2022 |
| 36221119 | CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response. | Journal of Translational Medicine | 2022 |
| 35884417 | CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression. | Cancers | 2022 |
| 35440537 | A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea. | Nature Communications | 2022 |
| 35629078 | Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. | Journal of Personalized Medicine | 2022 |
| 35565404 | Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial. | Cancers | 2022 |
| 36139501 | MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer. | Cells | 2022 |
| 36325689 | First-in-Human, Phase I Study of PCA062 in Solid Tumors-Letter. | Molecular Cancer Therapeutics | 2022 |
| 35984905 | Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias. | Blood | 2022 |
| 35354920 | RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia. | Leukemia | 2022 |
| 35920001 | TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. | EMBO Molecular Medicine | 2022 |
| 36778666 | Simple Affinity-Based Method for Concentrating Viruses from Wastewater Using Engineered Curli Fibers. | | 2022 |
| 34799485 | Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation. | American Journal of Surgical Pathology | 2022 |
| 35042871 | Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. | NPJ Breast Cancer | 2022 |
| 35267618 | CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. | Cancers | 2022 |
| 35205679 | Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients. | Cancers | 2022 |
| 35017155 | Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. | J Immunother Cancer | 2022 |
| 34711954 | Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity. | Oncogene | 2022 |
| 34373650 | Addendum: The mutational constraint spectrum quantified from variation in 141,456 humans. | Nature | 2021 |
| 33536625 | Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans. | Nature | 2021 |
| 34227743 | WEE1 Dependency and Pejorative Prognostic Value in Triple-Negative Breast Cancer. | Advanced Science | 2021 |
| 33850160 | EFA6B regulates a stop signal for collective invasion in breast cancer. | Nature Communications | 2021 |
| 34006291 | Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial. | Genome Medicine | 2021 |
| 33953185 | The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer. | npj Breast Cancer | 2021 |
| 34104544 | Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors. | Oncoimmunology | 2021 |
| 34141524 | Hybrid Living Capsules Autonomously Produced by Engineered Bacteria. | Advanced Science | 2021 |
| 34334687 | High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B. | American Journal of Surgical Pathology | 2021 |
| 33547202 | Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. | Clin Cancer Res | 2021 |
| 33547202 | Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. | Clin Cancer Res | 2021 |
| 34781168 | TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients. | European Journal of Cancer | 2021 |
| 31340059 | Targeted molecular characterization shows differences between primary and secondary myelofibrosis. | Genes Chromosomes and Cancer | 2020 |
| 31601691 | Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias. | Haematologica | 2020 |
| 31854063 | NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. | Mol Oncol | 2020 |
| 32195331 | The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype. | npj Breast Cancer | 2020 |
| 31960955 | Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoing resection. | British Journal of Surgery | 2020 |
| 32183347 | Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC. | Cancers | 2020 |
| 32409717 | Author Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations. | Nat Struct Mol Biol | 2020 |
| 32171674 | Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study. | | 2020 |
| 32350520 | Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. | Blood | 2020 |
| 32110798 | EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas. | Blood | 2020 |
| 31882477 | Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer. | In Vivo | 2020 |